Titolazione individualizzata del sodio oxibato in un disturbo da uso di alcol con uso improprio di benzodiazepine: un case report sulla personalizzazione della cura e la gestione sequenziale degli obiettivi terapeutici

Journal title MISSION
Author/s Elena Tamussi
Publishing Year 2026 Issue 2026/74
Language Italian Pages 3 P. 55-57 File size 0 KB
DOI 10.3280/mis74-2026oa23188
DOI is like a bar code for intellectual property: to have more infomation click here

View article Download Open Access article

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

  1. World Health Organization (2024). Global status report on alcohol and health 2024. Geneva: WHO.
  2. Rehm J., Anderson P., Manthey J. et al. (2021). Alcohol use and burden. Alcohol Alcohol., 56(4): 422-427.
  3. Kwako L.E., Momenan R., Litten R.Z. et al. (2016). Addictions neurobiology. Biol Psychiatry, 80(3): 179-189.
  4. Addolorato G., Leggio L., Ferrulli A. et al. (2006). Baclofen/GHB and alcohol dependence. Lancet, 367: 1503-1510.
  5. Addolorato G., Caputo F., Capristo E. et al. (2009). GHB in alcohol dependence. Alcohol., 43(2): 133-139.
  6. Caputo F., Vignoli T., Leggio L., Addolorato G., & Bernardi M. (2014). Pharmacological management of alcohol dependence. Expert Opin Pharmacother., 15(2): 245-257.
  7. Mann K., & Soyka M. (2017). Pharmacotherapy of alcohol dependence. CNS Drugs., 31(4): 255-272.
  8. Witkiewitz K., Litten R.Z., & Leggio L. (2019). Advances in AUD treatment science. Sci Adv., 5(9), eaax4043.
  9. Kwako L.E., Schwandt M.L., Ramchandani V.A. et al. (2019). Neurofunctional domains in AUD. Biol Psychiatry., 86(11): 866-879.
  10. Caputo F., Addolorato G., Capristo E. et al. (2010). Sodium oxybate in AUD. Expert Opin Pharmacother., 16(19): 2114-2117.
  11. European Association for the Study of the Liver (EASL) (2018). Alcohol-related liver disease guidelines. J Hepatol., 69(1): 154-181.
  12. American Psychiatric Association (2018). Practice guideline for AUD. Am J Psychiatry., 175(1): 86-90.
  13. Volkow N.D., Koob G.F., & McLellan A.T. (2016). Brain disease model of addiction. N Engl J Med., 374(4): 363-371.
  14. McLellan A.T., Lewis D.C., O’Brien C.P., & Kleber H.D. (2000). Addiction as chronic illness. JAMA, 284(13): 1689-1695.
  15. National Institute for Health and Care Excellence (NICE) (2011). CG115 Alcohol-use disorders. London: NICE.
  16. Saitz R. (2005). Unhealthy alcohol use. N Engl J Med., 352(6): 596-607.
  17. Caputo F., Domenicali M., et al. (2016). Sodium oxybate effi cacy. Alcohol Alcohol., 51(3): 312-318.
  18. Skala K., Caputo F., Mirijello A., et al. (2014). Sodium oxybate in AUD. Expert Opin Pharmacother., 15(2): 245-257.

Elena Tamussi, Titolazione individualizzata del sodio oxibato in un disturbo da uso di alcol con uso improprio di benzodiazepine: un case report sulla personalizzazione della cura e la gestione sequenziale degli obiettivi terapeutici in "MISSION" 74/2026, pp 55-57, DOI: 10.3280/mis74-2026oa23188